These variants (e.g. within TYR, GLI3 and upstream of GLI2) may influence only the initial development of early pathologic features of AMD such as RPE abnormalities and large soft drusen, with alternative pathways mediating disease progression once early stage changes have accumulated. The gene discussed is TYR; the disease is age-related macular degeneration.